Literature DB >> 7976265

Screening for eye disease in type 2 diabetes mellitus.

J K Kristinsson1, E Stefánsson, F Jónasson, I Gíslason, S Björnsson.   

Abstract

A screening program for diabetic eye disease was established in Iceland in 1980. Approximately 90% of the insulin dependent patients in Iceland undergo annual eye examination and fundus photography and about a fifth of the type 2 diabetic patients. We report on 245 diabetic patients with type 2 diabetes. Any diabetic retinopathy was present in 100 patients (41%), proliferative retinopathy had been present in 17 (7%) and 24 (10%) had clinically significant diabetic macular edema. Two-hundred and twenty-four patients (91%) had visual acuity equal or better than 6/12 in their better eye, 17 patients (7%) with 6/18-6/36 in their better eye, and 4 patients (1.6%) equal or worse than 6/60 in their better eye.

Entities:  

Mesh:

Year:  1994        PMID: 7976265     DOI: 10.1111/j.1755-3768.1994.tb02770.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  9 in total

Review 1.  Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model.

Authors:  M O Bachmann; S J Nelson
Journal:  J Epidemiol Community Health       Date:  1998-01       Impact factor: 3.710

2.  Retinal vessel dilatation and elongation precedes diabetic macular oedema.

Authors:  J K Kristinsson; M S Gottfredsdóttir; E Stefánsson
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

3.  Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R).

Authors:  E Gunnlaugsdottir; S Halldorsdottir; R Klein; G Eiriksdottir; B E Klein; R Benediktsson; T B Harris; L J Launer; T Aspelund; V Gudnason; M F Cotch; F Jonasson
Journal:  Diabetologia       Date:  2011-12-02       Impact factor: 10.122

4.  Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.

Authors:  T Aspelund; O Thornórisdóttir; E Olafsdottir; A Gudmundsdottir; A B Einarsdóttir; J Mehlsen; S Einarsson; O Pálsson; G Einarsson; T Bek; E Stefánsson
Journal:  Diabetologia       Date:  2011-07-27       Impact factor: 10.122

5.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.

Authors:  E Olafsdóttir; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2007-07-12       Impact factor: 4.638

Review 6.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

Review 7.  Screening Intervals for Diabetic Retinopathy and Implications for Care.

Authors:  Peter H Scanlon
Journal:  Curr Diab Rep       Date:  2017-09-05       Impact factor: 4.810

Review 8.  Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic.

Authors:  Philip I Burgess; Gerald Msukwa; Nicholas A V Beare
Journal:  BMC Med       Date:  2013-07-02       Impact factor: 8.775

Review 9.  The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence.

Authors:  Josef Huemer; Siegfried K Wagner; Dawn A Sim
Journal:  Clin Ophthalmol       Date:  2020-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.